Article Information
vol. 4 no. 1
Published By
Online ISSN
History
- Received October 11, 2017
- Accepted January 29, 2018
- Published online March 13, 2018.
Copyright & Usage
The content of this work is ©the authors or their employers. Design and branding are ©ERS 2018 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- Elena K. Schneider1,2,
- Rachel M. McQuade3,
- Vincenzo C. Carbone4,
- Felisa Reyes-Ortega5,
- John W. Wilson6,7,
- Brenda Button6,7,
- Ayame Saito3,
- Daniel P. Poole3,
- Daniel Hoyer2,8,9,
- Jian Li10,11 and
- Tony Velkov1,2,11⇑
- 1Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia
- 2Dept of Pharmacology and Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Australia
- 3Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia
- 4Animal Science, AgResearch Limited, Palmerston North, New Zealand
- 5Dept of Applied Physics, Sciences Faculty, University of Granada, Granada, Spain
- 6Dept of Medicine, Monash University, The Alfred Hospital, Melbourne, Australia
- 7Cystic Fibrosis Service, The Alfred Hospital, Melbourne, Australia
- 8The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia
- 9Dept of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA
- 10Monash Biomedicine Discovery Institute, Dept of Microbiology, Monash University, Clayton, Australia
- 11These two authors contributed equally to this work
- Tony Velkov, Dept of Pharmacology and Therapeutics, The University of Melbourne, Parkville, Victoria 3010, Australia. E-mail: tony.velkov{at}unimelb.edu.au
Funding
National Institute of Allergy and Infectious Diseases
R01 AI111965American Society for Microbiology
National Health and Medical Research Council
Article usage
Altmetrics
Vol 4 Issue 1
Table of Contents
The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites
